195 related articles for article (PubMed ID: 38345134)
21. Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment-related toxicities following proton therapy for intracranial tumors.
Ödén J; Toma-Dasu I; Witt Nyström P; Traneus E; Dasu A
Med Phys; 2020 Feb; 47(2):342-351. PubMed ID: 31705671
[TBL] [Abstract][Full Text] [Related]
22. Quantification of biological range uncertainties in patients treated at the Krakow proton therapy centre.
Garbacz M; Gajewski J; Durante M; Kisielewicz K; Krah N; Kopeć R; Olko P; Patera V; Rinaldi I; Rydygier M; Schiavi A; Scifoni E; Skóra T; Skrzypek A; Tommasino F; Rucinski A
Radiat Oncol; 2022 Mar; 17(1):50. PubMed ID: 35264184
[TBL] [Abstract][Full Text] [Related]
23. Fraction-variant beam orientation optimization for intensity-modulated proton therapy.
Gu W; O'Connor D; Ruan D; Zou W; Dong L; Sheng K
Med Phys; 2020 Sep; 47(9):3826-3834. PubMed ID: 32564353
[TBL] [Abstract][Full Text] [Related]
24. Incorporating variable RBE in IMPT optimization for ependymoma.
Goudarzi HM; Lim G; Grosshans D; Mohan R; Cao W
J Appl Clin Med Phys; 2024 Jan; 25(1):e14207. PubMed ID: 37985962
[TBL] [Abstract][Full Text] [Related]
25. Impact of Multiple Beams on Plan Quality, Linear Energy Transfer Distribution, and Plan Robustness of Intensity Modulated Proton Therapy for Lung Cancer.
Shang H; Pu Y; Chen Z; Wang X; Yuan C; Jin X; Liu C
ACS Sens; 2021 Feb; 6(2):408-417. PubMed ID: 33125211
[TBL] [Abstract][Full Text] [Related]
26. Impact of respiratory motion on variable relative biological effectiveness in 4D-dose distributions of proton therapy.
Ulrich S; Wieser HP; Cao W; Mohan R; Bangert M
Acta Oncol; 2017 Nov; 56(11):1420-1427. PubMed ID: 28828913
[TBL] [Abstract][Full Text] [Related]
27. PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization.
Liu W; Frank SJ; Li X; Li Y; Zhu RX; Mohan R
Med Phys; 2013 Feb; 40(2):021709. PubMed ID: 23387732
[TBL] [Abstract][Full Text] [Related]
28. Introducing Proton Track-End Objectives in Intensity Modulated Proton Therapy Optimization to Reduce Linear Energy Transfer and Relative Biological Effectiveness in Critical Structures.
Traneus E; Ödén J
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):747-757. PubMed ID: 30395906
[TBL] [Abstract][Full Text] [Related]
29. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
Ödén J; Eriksson K; Toma-Dasu I
Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
[TBL] [Abstract][Full Text] [Related]
30. Influence of beam pruning techniques on LET and RBE in proton arc therapy.
Henjum H; Tjelta J; Fjæra LF; Pilskog S; Stokkevåg CH; Lyngholm E; Handeland AH; Ytre-Hauge KS
Front Oncol; 2023; 13():1155310. PubMed ID: 37731633
[TBL] [Abstract][Full Text] [Related]
31. Implementation of spot scanning dose optimization and dose calculation for helium ions in Hyperion.
Fuchs H; Alber M; Schreiner T; Georg D
Med Phys; 2015 Sep; 42(9):5157-66. PubMed ID: 26328967
[TBL] [Abstract][Full Text] [Related]
32. Radiobiological issues in proton therapy.
Mohan R; Peeler CR; Guan F; Bronk L; Cao W; Grosshans DR
Acta Oncol; 2017 Nov; 56(11):1367-1373. PubMed ID: 28826292
[TBL] [Abstract][Full Text] [Related]
33. The influence of breathing motion and a variable relative biological effectiveness in proton therapy of left-sided breast cancer.
Ödén J; Toma-Dasu I; Eriksson K; Flejmer AM; Dasu A
Acta Oncol; 2017 Nov; 56(11):1428-1436. PubMed ID: 28826308
[TBL] [Abstract][Full Text] [Related]
34. The impact of proton LET/RBE modeling and robustness analysis on base-of-skull and pediatric craniopharyngioma proton plans relative to VMAT.
Gutierrez A; Rompokos V; Li K; Gillies C; D'Souza D; Solda F; Fersht N; Chang YC; Royle G; Amos RA; Underwood T
Acta Oncol; 2019 Dec; 58(12):1765-1774. PubMed ID: 31429359
[No Abstract] [Full Text] [Related]
35. Incorporation of the LETd-weighted biological dose in the evaluation of breast intensity-modulated proton therapy plans.
Liu C; Zheng D; Bradley JA; Mailhot Vega RB; Zhang Y; Indelicato DJ; Mendenhall N; Liang X
Acta Oncol; 2021 Feb; 60(2):252-259. PubMed ID: 33063569
[TBL] [Abstract][Full Text] [Related]
36. Interlaced proton grid therapy - Linear energy transfer and relative biological effectiveness distributions.
Henry T; Ödén J
Phys Med; 2018 Dec; 56():81-89. PubMed ID: 30473384
[TBL] [Abstract][Full Text] [Related]
37. Clinical implementation in proton therapy of multi-field optimization by a hybrid method combining conventional PTV with robust optimization.
Tommasino F; Widesott L; Fracchiolla F; Lorentini S; Righetto R; Algranati C; Scifoni E; Dionisi F; Scartoni D; Amelio D; Cianchetti M; Schwarz M; Amichetti M; Farace P
Phys Med Biol; 2020 Feb; 65(4):045002. PubMed ID: 31851957
[TBL] [Abstract][Full Text] [Related]
38. The Organ Sparing Potential of Different Biological Optimization Strategies in Proton Therapy.
Henjum H; Dahle TJ; Fjæra LF; Rørvik E; Pilskog S; Stokkevåg CH; Mairani A; Ytre-Hauge KS
Adv Radiat Oncol; 2021; 6(6):100776. PubMed ID: 34765804
[TBL] [Abstract][Full Text] [Related]
39. Comparison of intensity modulated proton therapy beam configurations for treating thoracic esophageal cancer.
Oonsiri S; Kitpanit S; Kannarunimit D; Chakkabat C; Lertbutsayanukul C; Prayongrat A
Phys Imaging Radiat Oncol; 2022 Apr; 22():51-56. PubMed ID: 35514527
[TBL] [Abstract][Full Text] [Related]
40. Variance-based sensitivity analysis for uncertainties in proton therapy: A framework to assess the effect of simultaneous uncertainties in range, positioning, and RBE model predictions on RBE-weighted dose distributions.
Hofmaier J; Dedes G; Carlson DJ; Parodi K; Belka C; Kamp F
Med Phys; 2021 Feb; 48(2):805-818. PubMed ID: 33210739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
